INDIANAPOLIS, March 26 /PRNewswire/ -- A coalition of Indiana's leaders in research, medicine, public health, education, labor and business joined today to launch Hoosiers Work for Health (www.hoosiersworkforhealth.org) to stress the importance of preserving medical innovation. Co-chairs, former Indianapolis Mayor Bart Peterson, and the President of the Pacers Sports & Entertainment Jim Morris, kicked off the effort at the Indiana Statehouse.
Hoosiers Work for Health will highlight the importance of biopharmaceutical research and innovation on Indiana's economy. The partnership includes local chambers of commerce, research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical sector employees who work to provide a better quality of life to all Hoosiers. Hoosiers Work for Health will focus on providing information and educating Hoosiers about the sector and how it affects them.
Today's kickoff will initiate an aggressive, statewide education effort, focused on bringing Hoosiers together on the issues of healthcare access, provision and innovation. Our partners will hold informational meetings, health fairs and industry site visits to assure that all Hoosiers understand the impact of the life sciences sector in Indiana and how best to assure it continues to grow here at home.
"Hoosiers Work for Health was created to highlight its partners' dedication to innovation, research and development of new cures; their contributions to state and local philanthropic causes; and their far-reaching presence as an economic force," said co-chair, Jim Morris. "Our partners support policies that recognize the value of innovation and take steps to preserve and foster America's ability to innovate."
Hoosiers Work for Health is one of ten state chapters of We Work for Health, a national effort that is the driving force behind improving health care for millions of Americans and strengthening local and regional economies. This network seeks to demonstrate to federal policymakers, key opinion leaders and the media the need for strong public policy to promote innovation and, along with it, the health of Hoosiers and the economy.
"Many of the companies involved in the biopharmaceutical industry in Indiana also provide philanthropic outreach in local communities through grants and programs, supporting access to affordable health coverage and medicine, primary and secondary education, social services, arts and other community needs," said Bart Peterson, co-chair of Hoosiers Work for Health. "Our partners significantly contribute to the overall economic strength of the Indiana communities in which they are involved. By creating jobs, providing growth opportunities for related industries, fostering higher education in science and math, and generating tax revenue, this network creates a strong foundation that will help to provide stability and prosperity in the future."
In conjunction with today's kickoff rally at the Indiana Statehouse, Hoosiers Work for Health released a new economic study underscoring the biopharmaceutical industry's impact on Indiana's economy.
The new economic study, entitled The Biopharmaceutical Sector's Impact on the U.S. Economy: Analysis at the National, State, and Local Levels, was conducted by Archstone Consulting and Dr. Lawton R. Burns, Director, The Wharton Center for Health Management and Economics at The Wharton School,
The study showed that the presence of biopharmaceutical companies, and the jobs they support, make substantial contributions to state economies. By acting as a magnet for bioscience investment, biopharmaceutical companies in Indiana help transform our state and regional economy by drawing highly educated labor, attracting and enhancing research and educational institutions and industry.
"Despite an extremely difficult economic environment, the life sciences industry remains a valuable component to Indiana's economy through its contribution of highly skilled and high-paying jobs, indirect job creation, and significant expenditure on the research and development that fosters innovation," said John C. Lechleiter, Ph.D., chairman, president and CEO Eli Lilly and Company. "Just as important, Indiana's life sciences industry is making a difference for Hoosiers and for people worldwide, helping them to live better, more productive, and longer lives."
Lechleiter added, "As citizens in these challenging times, we need to encourage our political leaders to fix what is broken - but we also need to make sure we don't break what still works. Today, innovation in the life sciences is one of those things that still works."
A separate analysis by PhRMA, the results of which were released simultaneously, found that domestic research and development investment by PhRMA members accounted for roughly 70 percent of all R&D spending in 2008. The survey found that pharmaceutical research and biotechnology companies invested a record $65.2 billion in 2008, a roughly $2 billion increase over 2007. PhRMA member investment reached a record $50.3 billion, a nearly 5 percent increase over 2007.
Michael Eckstut, Principal and Life Sciences and Strategy Practice Leader, Archstone Consulting, commented, "Our research indicates that the biopharmaceutical sector has made a substantial contribution to U.S. economic growth, and that on average, this sector contributed more to GDP on a per employee basis and grew faster than the rest of the economy from 1996 to 2006."
In addition, the local presence of the biopharmaceutical industry has a job multiplier effect, supporting an even greater number of American jobs, the Archstone study found.
About Hoosiers Work for Health
Hoosiers Work for Health is the Indiana chapter of a national initiative that unites health consumers, biopharmaceutical company employees, vendors, suppliers and other business and community partners to demonstrate how these diverse groups are vital to the socioeconomic climate and provide shared benefits and a better quality of life to all. Specifically, the partnership includes local chambers of commerce and research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical research companies that work together to improve America's health care system and strengthen our economy. More information is available hoosiersworkforhealth.org.
Contact: Michael O'Connor, Hoosiers Work for Health, (317) 684-5473
|SOURCE Hoosiers Work for Health|
Copyright©2009 PR Newswire.
All rights reserved